Related references
Note: Only part of the references are listed.Consensus Recommendations of the German Consortium for Hereditary Breast and Ovarian Cancer
Kerstin Rhiem et al.
BREAST CARE (2022)
Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly- informed therapies despite heterogeneity
Lino Moehrmann et al.
NATURE COMMUNICATIONS (2022)
ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG)
David T. Miller et al.
GENETICS IN MEDICINE (2021)
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia
B. Dalmasso et al.
GENETICS IN MEDICINE (2021)
Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
Elise M. Fiala et al.
NATURE CANCER (2021)
Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group
D. Mandelker et al.
ANNALS OF ONCOLOGY (2019)
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Talia Golan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Improved indel detection in DNA and RNA via realignment with ABRA2
Lisle E. Mose et al.
BIOINFORMATICS (2019)
Pathogenic Germline Variants in 10,389 Adult Cancers
Kuan-lin Huang et al.
CELL (2018)
The landscape of genomic alterations across childhood cancers
Susanne N. Groebner et al.
NATURE (2018)
Strelka2: fast and accurate calling of germline and somatic variants
Sangtae Kim et al.
NATURE METHODS (2018)
Integrating somatic variant data and biomarkers for germline variant classification in cancer predisposition genes
Michael F. Walsh et al.
HUMAN MUTATION (2018)
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
K. Moore et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing
Diana Mandelker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Germline ATM mutations in families with early-onset and familial gastroesophageal and colorectal cancers.
Michael J. Hall et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
Mark Robson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial
Christophe Massard et al.
CANCER DISCOVERY (2017)
Pancreatic non-functioning neuroendocrine tumor: a new entity genetically related to Lynch syndrome
Anna Serracant Barrera et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2017)
SeqPurge: highly-sensitive adapter trimming for paired-end NGS data
Marc Sturm et al.
BMC BIOINFORMATICS (2016)
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 Blockade
Douglas B. Johnson et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA
Kasmintan A. Schrader et al.
JAMA ONCOLOGY (2016)
The Ensembl Variant Effect Predictor
William McLaren et al.
GENOME BIOLOGY (2016)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial
Christophe Le Tourneau et al.
LANCET ONCOLOGY (2015)
Germline Mutations in Predisposition Genes in Pediatric Cancer
Jinghui Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Personalized genomic analyses for cancer mutation discovery and interpretation
Sian Jones et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Prevalence of deleterious ATM germline mutations in gastric cancer patients
Dong-Sheng Huang et al.
ONCOTARGET (2015)
A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment
Heather Hampel et al.
GENETICS IN MEDICINE (2015)
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing
Robert C. Green et al.
GENETICS IN MEDICINE (2013)